WHO ICTRP trial
Comparative study of the efficacy of adriamycin and liposome doxorubicin in the…
ChiCTR1800016574 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800016574 |
|---|---|
| Public title | Comparative study of the efficacy of adriamycin and liposome doxorubicin in the treatment of osteosarcoma |
| Scientific title | Comparative study of the efficacy of adriamycin and liposome doxorubicin in the treatment of osteosarcoma |
| Primary sponsor | Beijing Jishuitan Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Treatment study |
| Phase | Post-market |
| Countries | China |
| Conditions | Osteosarcoma |
| Interventions | Case series:Chemotherapy |
| Registration date | Jun 10, 2018 |
| Target size | Case series:150 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: